Literature DB >> 15466709

Small interfering RNA targeting Fas protects mice against renal ischemia-reperfusion injury.

Péter Hamar1, Erwei Song, Gabor Kökény, Allen Chen, Nengtai Ouyang, Judy Lieberman.   

Abstract

Fas-mediated apoptosis has been suggested to contribute to tubular cell death after renal ischemia-reperfusion injury. Here we investigate whether small interfering RNA (siRNA) duplexes targeting Fas protect mice from acute renal failure after clamping of the renal artery. Renal ischemia-reperfusion injury was induced by clamping the renal vein and artery for 15 or 35 min. Mice were treated before or after ischemia with siRNA targeting Fas or a control gene, administered by hydrodynamic injection, low-volume renal vein injection, or both. Treated mice were evaluated for renal Fas protein and mRNA expression, tissue histopathology, and apoptosis by terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling (TUNEL) staining. Blood urea nitrogen and survival were monitored in mice in which the contralateral kidney had been removed. A single hydrodynamic injection of Fas siRNA reduced Fas mRNA and protein expression in the kidney 4-fold. Kidneys from mice that received Fas siRNA two days earlier had substantially less renal tubular apoptosis by TUNEL staining and less tubular atrophy and hyaline damage. Whereas 90% of mice pretreated with saline or GFP siRNA died, only 20% of Fas-siRNA-pretreated animals died. The same survival advantage was provided by a single low-volume Fas siRNA injection into the renal vein. Moreover, postischemic injection through the renal vein protected 38% of mice from death. This study confirms the importance of Fas-mediated apoptosis in renal ischemia-reperfusion injury. Silencing Fas by systemic or local catheterization holds therapeutic promise to limit ischemia-reperfusion injury.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15466709      PMCID: PMC522049          DOI: 10.1073/pnas.0406421101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA.

Authors:  G Zhang; V Budker; J A Wolff
Journal:  Hum Gene Ther       Date:  1999-07-01       Impact factor: 5.695

2.  Peripheral LPS administrations up-regulate Fas and FasL on brain microglial cells: a brain protective or pathogenic event?

Authors:  Salvatore Terrazzino; Alessia Bauleo; Andrea Baldan; Alberta Leon
Journal:  J Neuroimmunol       Date:  2002-03       Impact factor: 3.478

3.  Induction of apoptosis in ischemia-reperfusion model of mouse kidney: possible involvement of Fas.

Authors:  S Nogae; M Miyazaki; N Kobayashi; T Saito; K Abe; H Saito; P K Nakane; Y Nakanishi; T Koji
Journal:  J Am Soc Nephrol       Date:  1998-04       Impact factor: 10.121

4.  Leukocyte accumulation and changes in extra-renal organs during renal ischemia reperfusion in mice.

Authors:  Shinobu Miyazawa; Hisami Watanabe; Chikako Miyaji; Osamu Hotta; Toru Abo
Journal:  J Lab Clin Med       Date:  2002-05

5.  Therapeutic neutralization of CD95-ligand and TNF attenuates brain damage in stroke.

Authors:  A Martin-Villalba; M Hahne; S Kleber; J Vogel; W Falk; J Schenkel; P H Krammer
Journal:  Cell Death Differ       Date:  2001-07       Impact factor: 15.828

6.  Kidney-targeted naked DNA transfer by retrograde renal vein injection in rats.

Authors:  Hiroki Maruyama; Noboru Higuchi; Yuji Nishikawa; Hiroyuki Hirahara; Noriaki Iino; Shigemi Kameda; Hiroshi Kawachi; Eishin Yaoita; Fumitake Gejyo; Jun-Ichi Miyazaki
Journal:  Hum Gene Ther       Date:  2002-02-10       Impact factor: 5.695

Review 7.  Shutdown of translation: lethal or protective? Unfolded protein response versus apoptosis.

Authors:  Wulf Paschen
Journal:  J Cereb Blood Flow Metab       Date:  2003-07       Impact factor: 6.200

8.  Activation of mitochondrial apoptotic pathways in human renal allografts after ischemiareperfusion injury.

Authors:  M Patricia Castaneda; Agnieszka Swiatecka-Urban; Mark M Mitsnefes; Dianne Feuerstein; Frederick J Kaskel; Vivian Tellis; Prasad Devarajan
Journal:  Transplantation       Date:  2003-07-15       Impact factor: 4.939

9.  Activation of the interferon system by short-interfering RNAs.

Authors:  Carol A Sledz; Michelle Holko; Michael J de Veer; Robert H Silverman; Bryan R G Williams
Journal:  Nat Cell Biol       Date:  2003-08-24       Impact factor: 28.824

10.  Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells.

Authors:  Peter C Scacheri; Orit Rozenblatt-Rosen; Natasha J Caplen; Tyra G Wolfsberg; Lowell Umayam; Jeffrey C Lee; Christina M Hughes; Kalai Selvi Shanmugam; Arindam Bhattacharjee; Matthew Meyerson; Francis S Collins
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-09       Impact factor: 11.205

View more
  88 in total

1.  IL-18 mediates proapoptotic signaling in renal tubular cells through a Fas ligand-dependent mechanism.

Authors:  Hongji Zhang; Karen L Hile; Hiroshi Asanuma; Brian Vanderbrink; Ethan I Franke; Matthew T Campbell; Kirstan K Meldrum
Journal:  Am J Physiol Renal Physiol       Date:  2011-04-20

Review 2.  Gene therapy targeting kidney diseases: routes and vehicles.

Authors:  Yoshitaka Isaka
Journal:  Clin Exp Nephrol       Date:  2006-12-20       Impact factor: 2.801

3.  Fas (CD95) induces macrophage proinflammatory chemokine production via a MyD88-dependent, caspase-independent pathway.

Authors:  William A Altemeier; Xiaodong Zhu; William R Berrington; John M Harlan; W Conrad Liles
Journal:  J Leukoc Biol       Date:  2007-06-18       Impact factor: 4.962

Review 4.  Therapeutic regulation of gene expression in the inner ear using RNA interference.

Authors:  Yukihide Maeda; Abraham M Sheffield; Richard J H Smith
Journal:  Adv Otorhinolaryngol       Date:  2009-06-02

Review 5.  Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application.

Authors:  Aimee L Jackson; Peter S Linsley
Journal:  Nat Rev Drug Discov       Date:  2010-01       Impact factor: 84.694

6.  Small interfering RNA targeting TNF-α gene significantly attenuates renal ischemia-reperfusion injury in mice.

Authors:  Ling Hou; Gang Chen; Biao Feng; Xu-Sheng Zhang; Xiu-Fen Zheng; Ying Xiang; Guang-Yuan Zhao; Wei-Ping Min
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-10-18

7.  Xenon preconditioning protects against renal ischemic-reperfusion injury via HIF-1alpha activation.

Authors:  Daqing Ma; Ta Lim; Jing Xu; Haidy Tang; Yanjie Wan; Hailin Zhao; Mahmuda Hossain; Patrick H Maxwell; Mervyn Maze
Journal:  J Am Soc Nephrol       Date:  2009-01-14       Impact factor: 10.121

8.  Zag expression during aging suppresses proliferation after kidney injury.

Authors:  Roland Schmitt; Arnaud Marlier; Lloyd G Cantley
Journal:  J Am Soc Nephrol       Date:  2008-09-24       Impact factor: 10.121

9.  The death ligand TRAIL in diabetic nephropathy.

Authors:  Corina Lorz; Alberto Benito-Martín; Anissa Boucherot; Alvaro C Ucero; Maria Pia Rastaldi; Anna Henger; Silvia Armelloni; Beatriz Santamaría; Celine C Berthier; Matthias Kretzler; Jesus Egido; Alberto Ortiz
Journal:  J Am Soc Nephrol       Date:  2008-02-20       Impact factor: 10.121

10.  RNAi-mediated silencing of nuclear factor erythroid-2-related factor 2 gene expression in non-small cell lung cancer inhibits tumor growth and increases efficacy of chemotherapy.

Authors:  Anju Singh; Swetlana Boldin-Adamsky; Rajesh K Thimmulappa; Srikanta K Rath; Hagit Ashush; Jonathan Coulter; Amanda Blackford; Steven N Goodman; Fred Bunz; Walter H Watson; Edward Gabrielson; Elena Feinstein; Shyam Biswal
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.